|
|
|
By BioPhorum | The pharma/biotech industry must ramp up adoption of digital certificates of analysis, which are transforming the way quality data is transferred between organizations in the supply chain. | |
|
|
2024 Made Us Nervous. Will 2025 Be A Happier New Year? | By Louis Garguilo, chief editor, Outsourced Pharma | Chief Editor Louis Garguilo doesn't recall a time of more collective concern over development and manufacturing outsourcing than exhibited during last year's news of Novo Holdings’ purchase of Catalent, and the sale of certain Catalent facilities to Novo Nordisk. That angst was aggravated by the simultaneous drama known as the BIOSECURE Act. Will we have a calmer 2025? |
|
|
|
|
The Future Of Small And Large Molecule Bioanalytics | White Paper | By Troy Voelker and Shane Karnik, Aliri Bioanalysis | Learn how spatial bioanalysis can provide answers regarding molecule function and form that can improve the quantity and quality of information obtainable in drug development studies. |
|
|
|
|
A Guide To CRO, CMO, And CDMO Partnerships | Article | Douglas CDMO | By partnering with a reputable CDMO, biotech and pharmaceutical companies can leverage their expertise and resources to expedite the development and manufacturing of life-saving medications. |
|
|
How To Secure A Sustainable Supply Of Raw Materials | Article | Pfizer CentreOne | How can pharma companies secure the supply of vital APIs and intermediates and maintain consistent manufacturing costs? These steps minimize supply chain insecurity in a rapidly changing market. |
|
|
|
|
|
Wrap-Around Pharmaceutical Labeler: HERMA 132M HC | HERMA | The 132M HC sets the standard for performance, precision, and reliability. This wrap-around labeler applies labels to cylindrical products with the utmost accuracy at the highest performance. |
|
|
Capacity Update October 2024: Fill/Finish | Lifecore Biomedical Services | Our injectables CDMO expertise can support your molecule, with a team skilled in complex formulations, over 20 commercial products, a 40+ year regulatory history, and a new isolator filler capacity. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|